Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00409396 · ClinicalTrials.gov registry record · NA
A Study to Determine Whether Urinary PGE-M Levels Correlate With Ulcerative Colitis Disease
A NA study, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT00409396 is a NA study that has completed, run by Vanderbilt University. The registered enrollment target is 35 participants.
The verdict
NCT00409396, a NA study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether urinary PGE-M levels correlate with Ulcerative Colitis Disease activity and to compare how well urinary PGEm correlates with other noninvasive biomarkers of disease activity such as CRP and fecal calprotectin.
Interventions
- PROCEDURE Urinary PGEm level
- PROCEDURE fecal calprotectin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2006-11 |
| Est. Completion | 2007-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00409396
The ClinicalTrials.gov registry entry for NCT00409396 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Urinary PGEm level is the first listed.
NCT00409396 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00409396 about?
NCT00409396 is a clinical study titled "A Study to Determine Whether Urinary PGE-M Levels Correlate With Ulcerative Colitis Disease". The purpose of this study is to determine whether urinary PGE-M levels correlate with Ulcerative Colitis Disease activity and to compare how well urinary PGEm correlates with other noninvasive biomarkers of disease activity such as CRP and fecal calprotectin.
What is the current status of trial NCT00409396?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2006-11. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00409396?
The interventions under investigation include: Urinary PGEm level (PROCEDURE), fecal calprotectin (PROCEDURE).
Who is sponsoring clinical trial NCT00409396?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.